SI-BONE (SIBN) Competitors $12.15 -0.17 (-1.38%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SIBN vs. SRDX, CRY, OFIX, ANIK, XENT, TNDM, RXST, NVCR, INMD, and MDXGShould you be buying SI-BONE stock or one of its competitors? The main competitors of SI-BONE include Surmodics (SRDX), CryoLife (CRY), Orthofix Medical (OFIX), Anika Therapeutics (ANIK), Intersect ENT (XENT), Tandem Diabetes Care (TNDM), RxSight (RXST), NovoCure (NVCR), InMode (INMD), and MiMedx Group (MDXG). These companies are all part of the "medical" sector. SI-BONE vs. Surmodics CryoLife Orthofix Medical Anika Therapeutics Intersect ENT Tandem Diabetes Care RxSight NovoCure InMode MiMedx Group SI-BONE (NASDAQ:SIBN) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability. Does the media refer more to SIBN or SRDX? In the previous week, SI-BONE had 17 more articles in the media than Surmodics. MarketBeat recorded 19 mentions for SI-BONE and 2 mentions for Surmodics. Surmodics' average media sentiment score of 0.93 beat SI-BONE's score of 0.77 indicating that Surmodics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SI-BONE 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Surmodics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate SIBN or SRDX? SI-BONE currently has a consensus target price of $23.00, suggesting a potential upside of 89.30%. Surmodics has a consensus target price of $50.00, suggesting a potential upside of 27.65%. Given SI-BONE's stronger consensus rating and higher possible upside, research analysts plainly believe SI-BONE is more favorable than Surmodics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Surmodics 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in SIBN or SRDX? Surmodics received 169 more outperform votes than SI-BONE when rated by MarketBeat users. However, 68.29% of users gave SI-BONE an outperform vote while only 63.58% of users gave Surmodics an outperform vote. CompanyUnderperformOutperformSI-BONEOutperform Votes16868.29% Underperform Votes7831.71% SurmodicsOutperform Votes33763.58% Underperform Votes19336.42% Which has better earnings and valuation, SIBN or SRDX? Surmodics has lower revenue, but higher earnings than SI-BONE. Surmodics is trading at a lower price-to-earnings ratio than SI-BONE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSI-BONE$138.89M3.67-$43.34M-$0.92-13.21Surmodics$126.08M4.43-$11.54M-$0.81-48.36 Which has more volatility and risk, SIBN or SRDX? SI-BONE has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SIBN or SRDX? 98.1% of SI-BONE shares are owned by institutional investors. Comparatively, 96.6% of Surmodics shares are owned by institutional investors. 3.9% of SI-BONE shares are owned by company insiders. Comparatively, 8.9% of Surmodics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is SIBN or SRDX more profitable? Surmodics has a net margin of -9.15% compared to SI-BONE's net margin of -23.82%. Surmodics' return on equity of -3.77% beat SI-BONE's return on equity.Company Net Margins Return on Equity Return on Assets SI-BONE-23.82% -22.51% -16.53% Surmodics -9.15%-3.77%-2.54% SummarySI-BONE and Surmodics tied by winning 9 of the 18 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get SI-BONE News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSI-BONESurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$509.57M$4.41B$5.03B$8.81BDividend YieldN/A41.16%5.16%4.06%P/E Ratio-13.2124.82135.4117.82Price / Sales3.6747.021,160.9774.56Price / CashN/A51.8733.5332.53Price / Book2.914.974.674.68Net Income-$43.34M$13.76M$119.07M$226.08M7 Day Performance-2.33%-1.08%-1.83%-1.04%1 Month Performance-5.67%0.58%-3.60%1.04%1 Year Performance-30.37%50.91%31.66%26.28% SI-BONE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSI-BONE4.3749 of 5 stars$12.15-1.4%$23.00+89.3%-32.6%$516.68M$138.89M-13.21350Analyst ForecastInsider TradeAnalyst RevisionSRDXSurmodics4.2112 of 5 stars$39.17-0.1%$50.00+27.6%+12.2%$559.12M$126.08M0.00376CRYCryoLife1.3011 of 5 starsN/AN/AN/A$703.22M$253.23M596.201,200Analyst ForecastOFIXOrthofix Medical1.3783 of 5 stars$18.87+0.7%$23.00+21.9%+74.4%$715.75M$746.64M0.001,634ANIKAnika Therapeutics2.8624 of 5 stars$17.18+0.8%$24.50+42.6%-16.6%$249.57M$164.17M-2.58357High Trading VolumeXENTIntersect ENTN/A$28.24flatN/A+0.0%$954.91M$106.75M-5.90433TNDMTandem Diabetes Care4.7481 of 5 stars$30.15+8.2%$54.25+79.9%+63.7%$1.83B$747.72M-15.622,400Positive NewsRXSTRxSight3.0052 of 5 stars$44.81-0.7%$61.63+37.5%+58.7%$1.82B$89.08M0.00220Insider TradeNVCRNovoCure3.7354 of 5 stars$16.86+2.3%$26.17+55.2%+38.3%$1.78B$509.34M0.001,453INMDInMode2.3302 of 5 stars$18.24+3.0%$22.60+23.9%-19.3%$1.49B$492.05M9.86480MDXGMiMedx Group3.1277 of 5 stars$9.06-1.9%$12.00+32.5%+26.4%$1.36B$321.48M16.47895 Related Companies and Tools Related Companies Surmodics Competitors CryoLife Competitors Orthofix Medical Competitors Anika Therapeutics Competitors Intersect ENT Competitors Tandem Diabetes Care Competitors RxSight Competitors NovoCure Competitors InMode Competitors MiMedx Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIBN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIBN Stock Alerts